Literature DB >> 2353579

Endothelium-independent potentiation by neuropeptide Y of vasoconstrictor responses in isolated arteries from rat and rabbit.

H Gustafsson1, H Nilsson.   

Abstract

An endothelium-dependent action of neuropeptide Y (NPY) has been implicated in studies on various vascular beds. In the present study, the requirement of an intact endothelium for NPY-evoked potentiation of the response to sympathetic nerve stimulation was determined in the small mesenteric arteries of the rat and in the central ear artery of the rabbit. Further, NPY-mediated inhibition of relaxing influences was determined in small mesenteric arteries of the rat. Vascular segments were mounted in a double myograph, where one of the two suspended vessels was denuded of endothelium by gently rubbing the intimal surface. Removal of endothelium was verified by en-face silver staining. In both species, the response to bursts of transmural field stimulation eliciting 10% of maximal contraction was potentiated 2-4 times in the presence of 10 nM NPY, whether the endothelium was present or not. In small mesenteric arteries precontracted with noradrenaline, addition of acetylcholine (I microM) caused relaxation only in vessels with an intact endothelium. Subsequent addition of 10 nM NPY enhanced vasoconstriction in both intact and endothelium-denuded vessels. The endothelium-independent beta-adrenergic agonist isoprenaline (I microM) relaxed both intact and denuded small mesenteric arteries, and in both further addition of 10 nM NPY increased the contraction to about the same extent. The results demonstrate that NPY potentiates the responses to sympathetic field stimulation in small mesenteric arteries from the rat and in central ear artery from rabbit whether the endothelium is present or not. NPY inhibits both endothelium-dependent and -independent relaxations in small mesenteric arteries from rat.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2353579     DOI: 10.1111/j.1748-1716.1990.tb08878.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  7 in total

1.  Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate).

Authors:  M Adamsson; B Fallgren; L Edvinsson
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

2.  Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y(1)-receptor in rat mesenteric small arteries.

Authors:  D Prieto; C L Buus; M J Mulvany; H Nilsson
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

3.  Evoked noradrenaline release in the rabbit ear artery: enhancement by purines, attenuation by neuropeptide Y and lack of effect of calcitonin gene-related peptide.

Authors:  K I Maynard; G Burnstock
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

Review 4.  Perivascular innervation: a multiplicity of roles in vasomotor control and myoendothelial signaling.

Authors:  Erika B Westcott; Steven S Segal
Journal:  Microcirculation       Date:  2013-04       Impact factor: 2.628

5.  Influence of estradiol supplementation on neuropeptide Y neurotransmission in skeletal muscle arterioles of F344 rats.

Authors:  Kirk W Evanson; Audrey J Stone; Enoch Samraj; Tyler Benson; Rhonda Prisby; Heidi A Kluess
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-07-25       Impact factor: 3.619

6.  Renovascular effects of neuropeptide-Y in the split hydronephrotic rat kidney: non-uniform pattern of vascular reactivity.

Authors:  M S Dietrich; M Fretschner; R Nobiling; P B Persson; M Steinhausen
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

7.  Synthesis and characterization of a selective peptide antagonist of neuropeptide Y vascular postsynaptic receptors.

Authors:  M J Lew; R Murphy; J A Angus
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.